SHARON STARUCH-CHRISTOPHER: Open Payments
NPI 1720332851 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 71 payments from 16 companies in 2025. Trend: 2023 $1,112 · 2024 $1,538 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $351 |
| ABBVIE INC. | 20 | $291 |
| UCB, Inc. | 12 | $232 |
| Arcutis Biotherapeutics, Inc. | 3 | $122 |
| Janssen Biotech, Inc. | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Organon LLC | 5 | $65 |
| Incyte Corporation | 2 | $44 |
| LEO Pharma Inc. | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
Products named: DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, Zoryve, TREMFYA, Rhapsido, OPZELURA.
Industry payments across GA — which companies pay providers there.
